Teleflex Inc (TFX) 186.11 $TFX Zacks.com featured

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Teleflex Inc (TFX) 186.11 $TFX

Zacks.com featured highlights: Teleflex, DST Systems, DuPont Fabros Technology, j2 Global, Heartland Financial USA and Acme United
Zacks Equity Research - Zacks Investment Research - 1 hr 30 mins ago
Zacks.com featured highlights: Teleflex, DST Systems, DuPont Fabros Technology, j2 Global, Heartland Financial USA and Acme United
DFT: 43.44 (+0.44), ACU: 21.16 (+0.32), JCOM: 68.84 (-0.14), HTLF: 36.62 (-0.50), TFX: 186.11 (+0.52), DST: 122.61 (-0.77)

6 GARP Stocks Poised to Yield Robust Returns
Zacks Equity Research - Zacks Investment Research - Fri Sep 02, 6:27AM CDT
Growth at a reasonable price or GARP investing is one of the popular strategies offering a blend of both growth as well as value investing.
DFT: 43.44 (+0.44), ACU: 21.16 (+0.32), JCOM: 68.84 (-0.14), TFX: 186.11 (+0.52), HTLF: 36.62 (-0.50), DST: 122.61 (-0.77)

Teleflex Up 27.0% Since SmarTrend Uptrend Call (TFX)
Comtex SmarTrend(R) - Thu Sep 01, 1:28PM CDT
SmarTrend identified an Uptrend for Teleflex (NYSE:TFX) on February 26th, 2016 at $145.22. In approximately 6 months, Teleflex has returned 26.95% as of today's recent price of $184.36.
TFX: 186.11 (+0.52)

Zacks.com featured highlights: Activision Blizzard, Teleflex, j2 Global, Heartland Financial and DuPont Fabros Technology
Zacks Equity Research - Zacks Investment Research - Fri Aug 19, 8:30AM CDT
Zacks.com featured highlights: Activision Blizzard, Teleflex, j2 Global, Heartland Financial and DuPont Fabros Technology
ATVI: 42.79 (-0.01), DFT: 43.44 (+0.44), JCOM: 68.84 (-0.14), HTLF: 36.62 (-0.50), TFX: 186.11 (+0.52)

Bet on These 5 GARP Stocks to Derive High Yields
Zacks Equity Research - Zacks Investment Research - Thu Aug 18, 8:18AM CDT
Growth at a reasonable price or GARP strategy is ideal for investors looking to enrich their portfolio by investing in stocks that have the potential to provide both value and growth investing.
ATVI: 42.79 (-0.01), DFT: 43.44 (+0.44), JCOM: 68.84 (-0.14), TFX: 186.11 (+0.52), HTLF: 36.62 (-0.50)

Teleflex Launches Advanced Percutaneous Surgical System
Zacks Equity Research - Zacks Investment Research - Wed Aug 17, 5:45AM CDT
Following the U.S. Food and Drug Administration's clearance, Teleflex Incorporated (TFX) announced the launch of its second generation Percuvance Percutaneous Surgical system.
BABY: 40.22 (-0.42), TFX: 186.11 (+0.52), IDXX: 113.89 (-0.20), CRY: 16.16 (-0.07)

TELEFLEX (TFX) SHAREHOLDER ALERT - Andrews & Springer LLC Is Investigating Teleflex Incorporated For Potential Breaches of Fiduciary Duty
BusinessWire - Mon Aug 15, 7:03AM CDT
Andrews & Springer LLC, a boutique securities class action law firm focused on representing shareholders nationwide, is investigating potential breach of fiduciary duty claims against Teleflex Incorporated (NYSE:TFX) ("Teleflex" or the "Company".
TFX: 186.11 (+0.52)

Teleflex Launches New Second-Generation 2.9 mm Percuvance(R) System - A Breakthrough Advance that Makes Percutaneous Approach to Laparoscopic Procedures Even Less Invasive
BusinessWire - Mon Aug 15, 5:45AM CDT
--Teleflex Launches Ambitious Efforts to Accelerate Growing Acceptance Worldwide of Percutaneous Laparoscopy Now Performed in 14 Countries
TFX: 186.11 (+0.52)

Teleflex Has Returned 23.9% Since SmarTrend Recommendation (TFX)
Comtex SmarTrend(R) - Wed Aug 10, 1:10AM CDT
SmarTrend identified an Uptrend for Teleflex (NYSE:TFX) on February 26th, 2016 at $145.22. In approximately 6 months, Teleflex has returned 23.85% as of today's recent price of $179.86.
TFX: 186.11 (+0.52)

Teleflex Announces Quarterly Dividend
BusinessWire - Thu Jul 28, 5:44AM CDT
Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock. The dividend is payable September 15, 2016 to shareholders of record at the close of business on August 15, 2016.
TFX: 186.11 (+0.52)

Teleflex Reports Second Quarter 2016 Results
BusinessWire - Thu Jul 28, 5:30AM CDT
--Second Quarter GAAP Diluted EPS of $1.25, Up 34.4% Over the Prior Year Period
TFX: 186.11 (+0.52)

Teleflex to Present Innovative New Vascular Access Technologies at World Congress on Vascular Access 2016 ("WoCoVA", in Lisbon, Portugal
BusinessWire - Fri Jun 17, 5:45AM CDT
Teleflex Incorporated (NYSE: TFX) will showcase three Arrow(R) Products at the World Congress of Vascular Access (WoCoVA) in Lisbon June 22-24 in preparation for their international launch.
TFX: 186.11 (+0.52)

Teleflex to present at Social Media and Critical Care Conference (SMACC) in Dublin, Ireland
BusinessWire - Fri Jun 10, 5:45AM CDT
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for critical care, urology and surgery, is committed to connecting clinicians with technology in a way that improves clinical practice and advances patient outcomes. Teleflex will present its innovative intraosseous vascular access system, products for rescue airway, atomization and intubation needs at the first Social Media and Critical Care Conference ("SMACC" in Dublin, Ireland on June 13-16, 2016.
TFX: 186.11 (+0.52)

Teleflex to Present at William Blair 36th Annual Growth Stock Conference
BusinessWire - Tue May 31, 5:45AM CDT
Liam Kelly, President and Chief Operating Officer, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the William Blair 36th Annual Growth Stock Conference at the Four Seasons Hotel in Chicago, Illinois, on Tuesday, June 14, 2016 at 2:50 p.m. (CT).
TFX: 186.11 (+0.52)

Teleflex to Present at First European Emergency Medical Service Congress ("EMS2016" in Copenhagen
BusinessWire - Thu May 26, 5:45AM CDT
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for critical care, urology and surgery, is committed to connecting clinicians with technology in a way that improves clinical practice and advances patient outcomes. Teleflex will showcase its Arrow(R) EZ-IO(R) Intraosseous Vascular Access System and other products for rescue airway, atomization and intubation needs at the first European Emergency Medical Service Congress ("EMS 2016" to be held in Copenhagen, Denmark, on May 30-June 1, 2016.
TFX: 186.11 (+0.52)

Teleflex to Showcase Key Anaesthesia Products at Euroanaesthesia 2016 ("ESA" in London
BusinessWire - Tue May 24, 5:45AM CDT
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for Critical Care, Urology and Surgery, will showcase the new LMA(R) Protector(TM) and other key products in its striking Anaesthesia portfolio, together with its innovative Vascular Access platform, at the Euroanaesthesia Congress in London, UK on May 28 - 30, 2016.
TFX: 186.11 (+0.52)

Teleflex to Present at the 53rd European Renal, Dialysis and Transplant Congress (ERA-EDTA)
BusinessWire - Wed May 18, 5:45AM CDT
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for critical care, urology and surgery, will showcase its range of interventional products at the 53rd European Renal, Dialysis and Transplant Congress in Vienna on May 21 - 24, 2016.
TFX: 186.11 (+0.52)

Teleflex Incorporated Selects Widen Media Collective to Manage Digital Media Distribution
Marketwired - Tue May 17, 9:58AM CDT
Medical Device Supplier Employs Digital Asset Management Solution to Centralize Media Storage Across the Globe
TFX: 186.11 (+0.52)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Beko Pushes for Policy Synergy Amidst Carbon Shakeup

Updated Category News Views 218

When big names like Beko step up on the global stage, you pay attention. During the COP31 panels in Antalya, Türkiye, the company's brass made one thing clear: we need harmony in how climate, trade, and finance policies come together. The stakes? The very strength of industrial competitiveness as new carbon rules turn the heat up on manufacturing practices. The Call for...

Continue Reading
Retirement Dreams Dashed: 61% Withdraw Early

Updated Category News Views 298

Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...

Continue Reading
WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Updated Category News Views 160

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 159

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 61

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
MV Transportation Celebrates Leadership Nomination for FTA

Updated Category News Views 225

MV Throws Support Behind Aesch for FTA Role In this wild world where public transit feels the heat from financial burdens, MV Transportation's recent move to support Mark Aesch for the Federal Transit Administration's top spot isn’t just a nod of approval—it's a full-blown trumpet blast. They're not just doling out a basic endorsement here; they're practically waving...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 126

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 321

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
PASCAL's Holiday Gift Edit: Timeless Watches Shine

Updated Category News Views 273

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 28

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading

Top 5 Most Recently Viewed Articles

McKinney's New Consumer PR Practice Sparks Marketing Buzz

Updated Category News Views 217

Market Dynamics Shifting: McKinney's Bold Move Let’s cut to the chase: McKinney’s launching a consumer PR practice—big deal, right? Well, hold your horses. This ain't just another agency spitting out press releases. They’re bringing in Jae Siercks, a heavy hitter from Weber Shandwick, to lead the charge. This kind of strategy echoes back to the days of the dot-com...

Continue Reading
Pariveda's Commitment: Winning Social Impact Partner Award

Updated Category News Views 218

Pariveda Recognized as Social Impact Partner of the Year Pariveda is proud to announce its recognition as the winner of the 2025 Geography and Global AWS Partner Award, highlighting its significant role as an innovator in the technology space. This prestigious award showcases the dedication of AWS Partners worldwide in advancing solutions using Amazon Web Services (AWS)....

Continue Reading
Eric A. Seiff: Celebrated Advocate in Criminal Defense for 2024

Updated Category News Views 179

Back in 2024, Eric A. Seiff was recognized among America’s Top 100 Criminal Defense Attorneys—a title only given to the absolute cream of the crop, with fewer than 0.5% of practicing attorneys making the cut. You gotta appreciate that level of distinction; it ain't just about being good—it’s about years spent fighting tooth and nail for what’s right in a...

Continue Reading
Wells Fargo Raises Price Target for Morgan Stanley Stock

Updated Category News Views 147

Wells Fargo Adjusts Morgan Stanley's Stock Outlook Recently, Wells Fargo reviewed its stance on Morgan Stanley (NYSE: MS), increasing the price target from $95.00 to $107.00. While this adjustment is a positive sign, the firm decided to keep an Underweight rating on the stock. The increase in the price target comes after Morgan Stanley's performance in the third quarter,...

Continue Reading
Raytone Biotech Begins RTP-008 Clinical Trial for Dry Eye Relief

Updated Category News Views 218

Raytone Biotech Begins RTP-008 Clinical Trial for Dry Eye Relief Raytone Biotech, a clinical-stage biotechnology company focused on innovative ophthalmic therapies, recently achieved a significant milestone by successfully completing the first patient dosing in its clinical trial for RTP-008. This new therapy is purposefully designed for those suffering from dry eye...

Continue Reading